Ikarian Capital, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 17, 2024), Ikarian Capital, LLC reported 82 stock positions worth $367.7 million. Its top holding was Crinetics Pharmaceuticals (CRNX) at 8.2% of the portfolio, followed by Tarsus Pharmaceuticals (TARS, 7.0%) and Soleno Therapeutics (SLNO, 6.6%). Compared with Q4 2023, it opened 24 new positions, sold out of 20, added to 22 and reduced 26. The biggest buy was Corbus Pharmaceuticals Holdi (CRBP, shares +185%) and the biggest sale an exit from Argenx SE - ADR (ARGX).
- Most Recent 13F
- Q2 2026
- Location
- DALLAS, TX
- CIK
- 0001778253
- Portfolio Value
- $367.7M (Q1 2024)
- SEC Filing
- 0001420506-24-001013 ↗ filed May 17, 2024
Holdings Value
Holdings 82 stocks · $367.7M
| CRNX Crinetics Pharmaceuticals Inc. | 8.20% | 643,751 | $30.1M | Reduce -5.4% |
| TARS Tarsus Pharmaceuticals Inc. | 7.02% | 710,277 | $25.8M | Add +37.0% |
| SLNO Soleno Therapeutics Inc. | 6.58% | 565,411 | $24.2M | Reduce -4.2% |
| CRBP Corbus Pharmaceuticals Holdi | 5.97% | 559,271 | $21.9M | Add +185.5% |
| SRPT Sarepta Therapeutics Inc. | 5.36% | 152,278 | $19.7M | Add +14.8% |
| AEROVATE THERAPEUTICS INC | 2.96% | 367,965 | $10.9M | New |
| SLRN Acelyrin Inc. | 2.87% | 1,564,340 | $10.6M | Reduce -21.4% |
| ALPN Alpine Immune Sciences Inc. | 2.82% | 261,365 | $10.4M | Reduce -46.4% |
| PRAX Praxis Precision Medicines I | 2.79% | 168,388 | $10.3M | Reduce -15.8% |
| CYTK Cytokinetics Inc. | 2.77% | 145,147 | $10.2M | Add +383.8% |
| ANNX Annexon Inc. | 2.74% | 1,405,000 | $10.1M | Reduce -47.0% |
| IMVT Immunovant Inc. | 2.43% | 276,925 | $8.9M | Add +18.6% |
| BBIO Bridgebio Pharma Inc. | 2.37% | 282,013 | $8.7M | Reduce -40.4% |
| CPRX Catalyst Pharmaceuticals Inc. | 2.25% | 518,386 | $8.3M | Add +2.5% |
| RCKT Rocket Pharmaceuticals Inc. | 2.18% | 297,096 | $8.0M | Add +23.9% |
| ALNY Alnylam Pharmaceuticals Inc. | 2.10% | 51,541 | $7.7M | New |
| NUVL Nuvalent Inc. Class A | 2.08% | 101,601 | $7.6M | Reduce -60.6% |
| PYXS Pyxis Oncology Inc. | 1.93% | 1,662,408 | $7.1M | New |
| LYRA Lyra Therapeutics Inc. | 1.79% | 1,056,829 | $6.6M | Reduce -15.8% |
| ABEO Abeona Therapeutics Inc. | 1.75% | 888,593 | $6.4M | Add +48.1% |
| VRNA Verona Pharma Ltd. | 1.64% | 375,310 | $6.0M | Add +2.1% |
| ARQT Arcutis Biotherapeutics Inc. | 1.59% | 589,642 | $5.8M | New |
| CYBIN INC | 1.57% | 13,953,488 | $5.8M | New |
| CRVO Cervomed Inc. | 1.50% | 237,345 | $5.5M | New |
| SRRK Scholar Rock Holding Corp. | 1.41% | 291,701 | $5.2M | New |
| MRNS Marinus Pharmaceuticals Inc. | 1.32% | 537,925 | $4.9M | Reduce -27.9% |
| MGNX Macrogenics Inc. | 1.27% | 318,167 | $4.7M | New |
| XENE Xenon Pharmaceuticals Inc. | 1.25% | 107,187 | $4.6M | New |
| NRIX Nurix Therapeutics Inc. | 1.20% | 300,000 | $4.4M | New |
| WVE Wave Life Sciences Ltd. | 0.99% | 590,088 | $3.6M | New |
| LRMR Larimar Therapeutics Inc. | 0.91% | 438,528 | $3.3M | Reduce -27.3% |
| JSPR Jasper Therapeutics Inc. | 0.84% | 105,175 | $3.1M | New |
| AEON BIOPHARMA INC | 0.81% | 257,977 | $3.0M | No change |
| MIND MEDICINE MINDMED INC | 0.76% | 297,481 | $2.8M | Reduce -50.4% |
| VTYX Ventyx Biosciences Inc. | 0.76% | 507,647 | $2.8M | Add +8483.8% |
| KOD Kodiak Sciences Inc. | 0.68% | 476,586 | $2.5M | Add +15.4% |
| TRML Tourmaline Bio Inc. | 0.68% | 108,483 | $2.5M | New |
| QURE Uniqure NV | 0.66% | 469,133 | $2.4M | Add +198.1% |
| IBIO Ibio Inc. | 0.66% | 600,000 | $2.4M | New |
| NUVB Nuvation Bio Inc. | 0.63% | 633,282 | $2.3M | Reduce -48.2% |
| SGMT Sagimet Biosciences Inc. Class A | 0.61% | 412,565 | $2.2M | New |
| IMUX Immunic Inc. | 0.58% | 1,612,378 | $2.1M | New |
| APLS Apellis Pharmaceuticals Inc. | 0.56% | 35,092 | $2.1M | Add +2.1% |
| ATXS Astria Therapeutics Inc. | 0.54% | 140,687 | $2.0M | Reduce -62.5% |
| LENZ Lenz Therapeutics Inc. | 0.52% | 85,000 | $1.9M | New |
| ACHL Achilles Therapeutics PL-ADR | 0.49% | 1,443,181 | $1.8M | New |
| VYGR Voyager Therapeutics Inc. | 0.46% | 180,857 | $1.7M | Reduce -40.9% |
| IRON Disc Medicine Inc. | 0.43% | 25,372 | $1.6M | Reduce -87.0% |
| INSM Insmed Inc. | 0.38% | 51,335 | $1.4M | New |
| RAPT THERAPEUTICS INC | 0.38% | 154,625 | $1.4M | New |
| ITOS Iteos Therapeutics Inc. | 0.38% | 101,325 | $1.4M | Reduce -70.8% |
| ALLK Allakos LLC | 0.32% | 932,675 | $1.2M | Add +293.4% |
| PRQR Proqr Therapeutics NV | 0.30% | 483,583 | $1.1M | Add +2.3% |
| IFRX Inflarx NV | 0.30% | 704,987 | $1.1M | Add +2.4% |
| ABOS Acumen Pharmaceuticals Inc. | 0.29% | 266,435 | $1.1M | Reduce -15.5% |
| ROIV Roivant Sciences Ltd. | 0.29% | 100,609 | $1.1M | Reduce -33.7% |
| AVTX Avalo Therapeutics Inc. | 0.28% | 46,648 | $1.0M | New |
| AVROBIO INC | 0.26% | 754,061 | $965K | Add +5.0% |
| AMLX Amylyx Pharmaceuticals Inc. | 0.26% | 331,451 | $941K | Reduce -62.2% |
| MIST Milestone Pharmaceuticals Inc. | 0.23% | 466,019 | $834K | Add +0.7% |
| TARA Protara Therapeutic Inc. | 0.22% | 202,701 | $813K | Add +7.4% |
| KEZAR LIFE SCIENCES INC | 0.21% | 868,992 | $783K | Add +1.8% |
| ELEV Elevation Oncology Inc. | 0.21% | 148,089 | $760K | Reduce -87.4% |
| NYXH Nyxoah SA | 0.19% | 50,699 | $684K | New |
| VERU Veru Inc. | 0.18% | 946,382 | $663K | New |
| KPTI Karyopharm Therapeutics Inc. | 0.17% | 409,355 | $618K | Add +2.3% |
| TERN Terns Pharmaceuticals Inc. | 0.16% | 88,497 | $581K | Reduce -46.5% |
| IMTX Immatics NV | 0.14% | 49,415 | $519K | Add +0.8% |
| ANEB Anebulo Pharmaceuticals Inc. | 0.12% | 157,862 | $453K | No change |
| TPST Tempest Therapeutics Inc. | 0.11% | 105,600 | $413K | No change |
| QTTB Q32 Bio Inc. | 0.10% | 22,335 | $381K | New |
| HOOKIPA PHARMA INC | 0.10% | 530,776 | $378K | No change |
| RLMD Relmada Therapeutics Inc. | 0.05% | 40,369 | $188K | No change |
| CMMB Chemomab Therapeutics Ltd. | 0.05% | 213,392 | $166K | No change |
| STOK Stoke Therapeutics Inc. | 0.03% | 6,816 | $92K | Reduce -43.7% |
| BCLI Brainstorm Cell Therapeutics | 0.01% | 90,242 | $51K | No change |
| SYBX Synlogic Inc. | 0.01% | 20,448 | $37K | No change |
| EYPT Eyepoint Inc. | 0.01% | 1,047 | $22K | Reduce -99.7% |
| FNCHQ Finch Therapeutics Group Inc. | 0.00% | 6,892 | $18K | No change |
| TYRA Tyra Biosciences Inc. | 0.00% | 501 | $8K | Reduce -99.0% |
| ASLAN PHARMACEUTICALS LTD | 0.00% | 35,420 | $6K | No change |
| LBPH Longboard Pharmaceuticals Inc. | 0.00% | 236 | $5K | Reduce -100.0% |
Options reported separately and not counted above: KRYS puts ($66.7M), XBI puts ($66.4M), CORT puts ($25.1M), IRON puts ($24.7M), AZN calls ($20.9M), ALNY puts ($20.4M), ALNY calls ($18.1M), KRYS calls ($17.8M), AMGN calls ($17.1M), VKTX puts ($16.4M), BMEA calls ($16.1M), SRPT calls ($15.0M), and 43 more.
Portfolio Sells Q4 2023 → Q1 2024
| ARGX Argenx SE - ADR | Sold out | 0.00% | −7.26 |
| XHB SS SPDR S&P Homebldrs ETF | Sold out | 0.00% | −5.23 |
| AMLX Amylyx Pharmaceuticals Inc. | Reduce -62.2% | 0.26% | −3.28 |
| NUVL Nuvalent Inc. Class A | Reduce -60.6% | 2.08% | −3.12 |
| BBIO Bridgebio Pharma Inc. | Reduce -40.4% | 2.37% | −2.85 |
| IRON Disc Medicine Inc. | Reduce -87.0% | 0.43% | −2.65 |
| EYPT Eyepoint Inc. | Reduce -99.7% | 0.01% | −2.32 |
| PTGX Protagonist Therapeutics Inc. | Sold out | 0.00% | −2.00 |
| ICVX Icosavax Inc. | Sold out | 0.00% | −1.90 |
| LBPH Longboard Pharmaceuticals Inc. | Reduce -100.0% | 0.00% | −1.61 |
| CABA Cabaletta Bio Inc. | Sold out | 0.00% | −1.35 |
| FUSN Fusion Pharmaceuticals Inc. | Sold out | 0.00% | −1.31 |
| CRSP Crispr Therapeutics AG | Sold out | 0.00% | −1.21 |
| SLRN Acelyrin Inc. | Reduce -21.4% | 2.87% | −1.19 |
| DYN Dyne Therapeutics Inc. | Sold out | 0.00% | −1.04 |
| MRNS Marinus Pharmaceuticals Inc. | Reduce -27.9% | 1.32% | −0.90 |
| EWTX Edgewise Therapeutics Inc. | Sold out | 0.00% | −0.81 |
| IMGN Immunogen Inc. | Sold out | 0.00% | −0.73 |
| MRNA Moderna Inc. | Sold out | 0.00% | −0.67 |
| ITOS Iteos Therapeutics Inc. | Reduce -70.8% | 0.38% | −0.66 |
| ANNX Annexon Inc. | Reduce -47.0% | 2.74% | −0.55 |
| AUTL Autolus Therapeutics PLC | Sold out | 0.00% | −0.46 |
| BDTX Black Diamond Therapeutics I | Sold out | 0.00% | −0.43 |
| CHRS Coherus Oncology Inc. | Sold out | 0.00% | −0.31 |
| ESPR Esperion Therapeutics Inc. | Sold out | 0.00% | −0.28 |
| LNTH Lantheus Holdings Inc. | Sold out | 0.00% | −0.25 |
| ATXS Astria Therapeutics Inc. | Reduce -62.5% | 0.54% | −0.25 |
| VYGR Voyager Therapeutics Inc. | Reduce -40.9% | 0.46% | −0.25 |
| RENEO PHARMACEUTICALS INC | Sold out | 0.00% | −0.18 |
| TYRA Tyra Biosciences Inc. | Reduce -99.0% | 0.00% | −0.18 |
| ROIV Roivant Sciences Ltd. | Reduce -33.7% | 0.29% | −0.18 |
| GPCR Structure Therapeutics Inc. | Sold out | 0.00% | −0.16 |
| TERN Terns Pharmaceuticals Inc. | Reduce -46.5% | 0.16% | −0.14 |
| TRACON PHARMACEUTICALS INC | Sold out | 0.00% | −0.13 |
| ABOS Acumen Pharmaceuticals Inc. | Reduce -15.5% | 0.29% | −0.04 |
| LYRA Lyra Therapeutics Inc. | Reduce -15.8% | 1.79% | −0.01 |
| ACRS Aclaris Therapeutics Inc. | Sold out | 0.00% | −0.01 |
| STOK Stoke Therapeutics Inc. | Reduce -43.7% | 0.03% | +0.01 |
| ELEV Elevation Oncology Inc. | Reduce -87.4% | 0.21% | +0.03 |
| SLNO Soleno Therapeutics Inc. | Reduce -4.2% | 6.58% | +0.08 |
| NUVB Nuvation Bio Inc. | Reduce -48.2% | 0.63% | +0.12 |
| LRMR Larimar Therapeutics Inc. | Reduce -27.3% | 0.91% | +0.15 |
| MIND MEDICINE MINDMED INC | Reduce -50.4% | 0.76% | +0.16 |
| ALPN Alpine Immune Sciences Inc. | Reduce -46.4% | 2.82% | +0.28 |
| CRNX Crinetics Pharmaceuticals Inc. | Reduce -5.4% | 8.20% | +1.57 |
| PRAX Praxis Precision Medicines I | Reduce -15.8% | 2.79% | +1.58 |
Portfolio Buys Q4 2023 → Q1 2024
| CRBP Corbus Pharmaceuticals Holdi | Add +185.5% | 5.97% | +5.65 |
| TARS Tarsus Pharmaceuticals Inc. | Add +37.0% | 7.02% | +4.15 |
| AEROVATE THERAPEUTICS INC | New | 2.96% | +2.96 |
| ALNY Alnylam Pharmaceuticals Inc. | New | 2.10% | +2.10 |
| CYTK Cytokinetics Inc. | Add +383.8% | 2.77% | +2.08 |
| PYXS Pyxis Oncology Inc. | New | 1.93% | +1.93 |
| SRPT Sarepta Therapeutics Inc. | Add +14.8% | 5.36% | +1.86 |
| ARQT Arcutis Biotherapeutics Inc. | New | 1.59% | +1.59 |
| VRNA Verona Pharma Ltd. | Add +2.1% | 1.64% | +1.57 |
| CYBIN INC | New | 1.57% | +1.57 |
| CRVO Cervomed Inc. | New | 1.50% | +1.50 |
| SRRK Scholar Rock Holding Corp. | New | 1.41% | +1.41 |
| MGNX Macrogenics Inc. | New | 1.27% | +1.27 |
| XENE Xenon Pharmaceuticals Inc. | New | 1.25% | +1.25 |
| NRIX Nurix Therapeutics Inc. | New | 1.20% | +1.20 |
| WVE Wave Life Sciences Ltd. | New | 0.99% | +0.99 |
| ABEO Abeona Therapeutics Inc. | Add +48.1% | 1.75% | +0.93 |
| JSPR Jasper Therapeutics Inc. | New | 0.84% | +0.84 |
| VTYX Ventyx Biosciences Inc. | Add +8483.8% | 0.76% | +0.76 |
| TRML Tourmaline Bio Inc. | New | 0.68% | +0.68 |
| IBIO Ibio Inc. | New | 0.66% | +0.66 |
| SGMT Sagimet Biosciences Inc. Class A | New | 0.61% | +0.61 |
| IMUX Immunic Inc. | New | 0.58% | +0.58 |
| LENZ Lenz Therapeutics Inc. | New | 0.52% | +0.52 |
| ACHL Achilles Therapeutics PL-ADR | New | 0.49% | +0.49 |
| INSM Insmed Inc. | New | 0.38% | +0.38 |
| RAPT THERAPEUTICS INC | New | 0.38% | +0.38 |
| QURE Uniqure NV | Add +198.1% | 0.66% | +0.37 |
| KOD Kodiak Sciences Inc. | Add +15.4% | 0.68% | +0.34 |
| AVTX Avalo Therapeutics Inc. | New | 0.28% | +0.28 |
| RCKT Rocket Pharmaceuticals Inc. | Add +23.9% | 2.18% | +0.21 |
| NYXH Nyxoah SA | New | 0.19% | +0.19 |
| VERU Veru Inc. | New | 0.18% | +0.18 |
| ALLK Allakos LLC | Add +293.4% | 0.32% | +0.14 |
| TARA Protara Therapeutic Inc. | Add +7.4% | 0.22% | +0.12 |
| QTTB Q32 Bio Inc. | New | 0.10% | +0.10 |
| KPTI Karyopharm Therapeutics Inc. | Add +2.3% | 0.17% | +0.07 |
| PRQR Proqr Therapeutics NV | Add +2.3% | 0.30% | +0.04 |
| MIST Milestone Pharmaceuticals Inc. | Add +0.7% | 0.23% | +0.02 |
| IMTX Immatics NV | Add +0.8% | 0.14% | 0.00 |
| APLS Apellis Pharmaceuticals Inc. | Add +2.1% | 0.56% | −0.00 |
| AVROBIO INC | Add +5.0% | 0.26% | −0.00 |
| KEZAR LIFE SCIENCES INC | Add +1.8% | 0.21% | −0.01 |
| IFRX Inflarx NV | Add +2.4% | 0.30% | −0.01 |
| CPRX Catalyst Pharmaceuticals Inc. | Add +2.5% | 2.25% | −0.08 |
| IMVT Immunovant Inc. | Add +18.6% | 2.43% | −0.26 |
Options Activity Q4 2023 → Q1 2024
| KRYS Krystal Biotech Inc. | put | Reduce -9.0% | 375,000 | $66.7M |
| XBI SS SPDR S&P Biotech ETF | put | Add +27.3% | 700,000 | $66.4M |
| CYTK Cytokinetics Inc. | call | Sold out | 603,500 | $50.4Mbefore exit |
| LLY Eli Lilly & Co. | put | Sold out | 70,000 | $40.8Mbefore exit |
| CRSP Crispr Therapeutics AG | put | Sold out | 649,400 | $40.7Mbefore exit |
| ARGX Argenx SE - ADR | call | Sold out | 78,100 | $29.7Mbefore exit |
| ARGX Argenx SE - ADR | put | Sold out | 78,100 | $29.7Mbefore exit |
| CORT Corcept Therapeutics Inc. | put | Add +266.6% | 994,500 | $25.1M |
| IRON Disc Medicine Inc. | put | New | 396,600 | $24.7M |
| PRTA Prothena Corp. PLC | call | Sold out | 600,000 | $21.8Mbefore exit |
| AZN Astrazeneca PLC-Spons ADR | call | New | 309,200 | $20.9M |
| ABBV Abbvie Inc. | call | Sold out | 132,500 | $20.5Mbefore exit |
| ALNY Alnylam Pharmaceuticals Inc. | put | Add +38.6% | 136,700 | $20.4M |
| KRTX Karuna Therapeutics Inc. | call | Sold out | 58,600 | $18.5Mbefore exit |
| ALNY Alnylam Pharmaceuticals Inc. | call | Reduce -28.8% | 120,800 | $18.1M |
| AMGN Amgen Inc. | call | Add +71.4% | 60,000 | $17.1M |
| VKTX Viking Therapeutics Inc. | put | New | 200,000 | $16.4M |
| BMEA Biomea Fusion Inc. | call | Add +38.6% | 1,077,600 | $16.1M |
| PRTA Prothena Corp. PLC | put | Sold out | 418,400 | $15.2Mbefore exit |
| SRPT Sarepta Therapeutics Inc. | call | Reduce -36.4% | 116,100 | $15.0M |
| CRNX Crinetics Pharmaceuticals Inc. | put | New | 300,400 | $14.1M |
| MDGL Madrigal Pharmaceuticals Inc. | put | New | 51,400 | $13.7M |
| EYPT Eyepoint Inc. | put | Add +132.4% | 658,200 | $13.6M |
| IMGN Immunogen Inc. | call | Sold out | 456,800 | $13.5Mbefore exit |
| IMVT Immunovant Inc. | call | Sold out | 300,700 | $12.7Mbefore exit |
| BHVN Biohaven Ltd. | call | New | 223,700 | $12.2M |
| BBIO Bridgebio Pharma Inc. | call | New | 389,400 | $12.0M |
| LNTH Lantheus Holdings Inc. | call | Reduce -37.0% | 170,000 | $10.6M |
| SRPT Sarepta Therapeutics Inc. | put | Sold out | 101,800 | $9.8Mbefore exit |
| INSM Insmed Inc. | call | Add +173500.0% | 347,200 | $9.4M |
| APLS Apellis Pharmaceuticals Inc. | call | Sold out | 150,000 | $9.0Mbefore exit |
| FDMT 4D Molecular Therapeutics Inc. | put | New | 257,600 | $8.2M |
| FDMT 4D Molecular Therapeutics Inc. | call | New | 257,600 | $8.2M |
| DYN Dyne Therapeutics Inc. | call | Sold out | 607,600 | $8.1Mbefore exit |
| MLTX Moonlake Immunotherapeutics | put | Reduce -21.2% | 158,000 | $7.9M |
| MGNX Macrogenics Inc. | call | New | 523,500 | $7.7M |
| NUVL Nuvalent Inc. Class A | call | Sold out | 104,400 | $7.7Mbefore exit |
| RCUS Arcus Biosciences Inc. | call | Sold out | 400,000 | $7.6Mbefore exit |
| XENE Xenon Pharmaceuticals Inc. | put | Sold out | 154,089 | $7.1Mbefore exit |
| CORT Corcept Therapeutics Inc. | call | Add +3.0% | 279,500 | $7.0M |
| CYTK Cytokinetics Inc. | put | Add +2757.1% | 100,000 | $7.0M |
| IMVT Immunovant Inc. | put | Sold out | 164,700 | $6.9Mbefore exit |
| SRRK Scholar Rock Holding Corp. | call | New | 362,300 | $6.4M |
| APLS Apellis Pharmaceuticals Inc. | put | New | 100,000 | $5.9M |
| ATXS Astria Therapeutics Inc. | call | New | 400,000 | $5.6M |
| GPCR Structure Therapeutics Inc. | put | New | 120,400 | $5.2M |
| JAZZ Jazz Pharmaceuticals PLC | call | Sold out | 41,800 | $5.1Mbefore exit |
| RCKT Rocket Pharmaceuticals Inc. | call | Sold out | 150,000 | $4.5Mbefore exit |
| MRNA Moderna Inc. | put | Sold out | 44,300 | $4.4Mbefore exit |
| NVAX Novavax Inc. | put | Sold out | 913,200 | $4.4Mbefore exit |
Showing the first 50 of 84.
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 126 | $610.9M | ABVX, KOD, ALMS, PRAX, PCVX |
| Q1 2026 | 127 | $699.0M | TERN, KOD, ALMS, PCVX, PRAX |
| Q4 2025 | 135 | $772.6M | TERN, CDTX, ABVX, JAZZ, MAZE |
| Q3 2025 | 116 | $494.3M | GMAB, ABVX, IONS, CDTX, MAZE |
| Q2 2025 | 103 | $302.2M | CDTX, ALNY, INSM, VRNA, CRNX |
| Q1 2025 | 116 | $306.9M | TARS, CRNX, SPY, SRPT, BPMC |
| Q4 2024 | 122 | $350.2M | TARS, CRNX, SRRK, BPMC, FBRX |
| Q3 2024 | 96 | $322.0M | TARS, CRNX, ELVN, RCUS, VRDN |
| Q2 2024 | 85 | $320.5M | SRPT, CRNX, TARS, SLNO, CRBP |
| Q1 2024Amended | 82 | $367.7M | CRNX, TARS, SLNO, CRBP, SRPT |